Síndrome del cascanueces / Nutcracker syndrome

No disponible

Pseudohermafroditismo masculino: genitales ambiguos / Male Pseudohermaphroditism: Ambiguous genitalia

No disponible

Estenosis de la anastomosis vesicouretral tras prostatectomía radical y radioterapia postoperatoria / Vesicourethral anastomotic stricture following radical prostatectomy with or without postoperative radiotherapy

Objetivo: conocer la incidencia de la estenosis de la anastomosis vesicouretral en pacientes con cáncer de próstata tratados con prostatectomía radical. El objetivo secundario fue analizar si la radioterapia postoperatoria incrementa el riesgo de presentar una estenosis de la anastomosis. Material y métodos: se revisaron retrospectivamente las historias de los pacientes sometidos a prostatectomía radical como tratamiento primario entre enero 2000 y diciembre del 2008, con un seguimiento clínico mínimo de 12 meses. Del total de pacientes 258 cumplían los requisitos anteriores. De ellos 25 (9,6%) recibieron radioterapia postoperatoria, 12 (48%) de forma adyuvante y 13 (52%) de rescate. La edad media de los pacientes irradiados fue 64 (46-77) años. La mediana del PSA pre-radioterapia fue 2,3 (0,04-26,1)ng/ ml. El tiempo medio entre la cirugía y la radioterapia fue 17,4 (3-72) meses. La dosis media administrada fue 68 (58-70) Gy. El seguimiento medio fue 50,5 (15-117) meses. Resultados: de 25 pacientes prostatectomizados que recibieron radioterapia 4 (16%) desarrollaron estenosis de la anastomosis vesicouretral. El tiempo medio desde la finalización de la radioterapia hasta la aparición de la estenosis fue de 4 meses (1-22). Por otro lado, 36 (15,4%) pacientes prostatectomizados que no recibieron radioterapia postoperatoria presentaron esta misma complicación. Comparativamente no se apreciaron diferencias significativas entre ambos grupos (p = 0,599).Conclusiones: en nuestra revisión retrospectiva, la radioterapia postoperatoria no incrementó de forma significativa la incidencia de estenosis de la anastomosis vesicouretral (AU)

Objective: To know the incidence of vesicourethral anastomotic stricture in patients with prostate cancer treated with radical prostatectomy. Our secondary aim was to verify if postoperative radiotherapy increases the risk of presenting anastomotic stricture. Materials and methods: We retrospectively checked the clinical records of patients that had undergone radical prostatectomy as their primary treatment between January 2000 and December2008, with a minimum clinical follow-up of 12 months. Of the total patients, 258 met the foregoing requirements. Of them, 25 (9.6%) received postoperative radiotherapy, 12 (48%) received adjuvant radiotherapy and 13 (52%) received salvage radiotherapy. The mean age of the patients that received radiotherapy was 64 (46-77) years. The mean pre-radiotherapy PSA was 2.3 (0.04-26.1) ng/ ml. The mean time between surgery and radiotherapy was 17.4 (3-72) months. The mean dosage administered was 68 (58-70) Gy. The mean follow-up was 50.5(15-177) months. Results: Of 25 prostatectomized patients that received radiotherapy, four (16%) developed vesicourethral anastomotic stricture. The mean time from the completion of the radiotherapy until the appearance of the stricture was 4 months (1-22). On the other hand, 36 (15.4%) of the prostatectomized patients that did not receive postoperative radiotherapy presented the same complication. Comparatively, we did not note significant differences between both groups (p = 0.599). Conclusions: In our retrospective review, postoperative radiotherapy did not significantly increase the incidence of vesicourethral anastomotic stricture (AU)

[Vesicourethral anastomotic stricture following radical prostatectomy with or without postoperative radiotherapy]. / Estenosis de la anastomosis vesicouretral tras prostatectomíaradical y radioterapia postoperatoria.

OBJECTIVE: To know the incidence of vesicourethral anastomotic stricture in patients with prostate cancer treated with radical prostatectomy. Our secondary aim was to verify if postoperative radiotherapy increases the risk of presenting anastomotic stricture. MATERIALS AND METHODS: We retrospectively checked the clinical records of patients that had undergone radical prostatectomy as their primary treatment between January 2000 and December 2008, with a minimum clinical follow-up of 12 months. Of the total patients, 258 met the foregoing requirements. Of them, 25 (9.6%) received postoperative radiotherapy, 12 (48%) received adjuvant radiotherapy and 13 (52%) received salvage radiotherapy. The mean age of the patients that received radiotherapy was 64 (46-77) years. The mean pre-radiotherapy PSA was 2.3 (0.04-26.1) ng/ ml. The mean time between surgery and radiotherapy was 17.4 (3-72) months. The mean dosage administered was 68 (58-70) Gy. The mean follow-up was 50.5 (15-177) months. RESULTS: Of 25 prostatectomized patients that received radiotherapy, four (16%) developed vesicourethral anastomotic stricture. The mean time from the completion of the radiotherapy until the appearance of the stricture was 4 months (1-22). On the other hand, 36 (15.4%) of the prostatectomized patients that did not receive postoperative radiotherapy presented the same complication. Comparatively, we did not note significant differences between both groups (p=0.599). CONCLUSIONS: In our retrospective review, postoperative radiotherapy did not significantly increase the incidence of vesicourethral anastomotic stricture.

RM del esfínter urinario artificial Flow-Secure® tras Prostatectomía radical / MRI of the Flow-SecureTM urinary sphincter

No disponible

Divertículo vesical / No disponible

No disponible

Fracaso tricompartimental de suelo pélvico / No disponible

No disponible

["FlowSecure" artificial urinary sphincter: a new adjustable artificial urinary sphincter concept with conditional occlusion for stress urinary incontinence]. / Implantación del esfínter urinario artificial "FlowSecure" en uretra bulbar: descripción de la técnica quirúrgica paso a paso.

INTRODUCTION: We have implanted the FlowSecure artificial sphincter for the first time in October 2006. The prototype was originally conceived and designed by Professor Craggs M. D. and Professor Mundy A.R. Preliminary clinical results were reported in nine patients early this year. Our objective is to spread technique for surgical implantation. METHODS: Combined perineal and abdominal incisions are required for exposure of bulbar urethra, creation of a cavity in the para-vesical space and dissection of a pocket under de scrotal wall. A trocar with a stylet is routed from the abdominal incision to the perineal incision to pass the deflated cuff to the perineal site. The cuff is placed around the urethra and secured with Prolene sutures. After refilling the cuff, fluid is removed from the system until the stress relief balloon becomes just indented (atmospheric pressure 0). The pump is placed in the scrotum and the balloons in the paravesical space. RESULTS: We have implanted our first FlowSecure artificial sphincter in a patient with severe stress incontinence following a T.U.R.P. The surgical technique is simple and associated with little handling. He was discharged from hospital 4 days after the procedure and it was decided that pressurisation was unnecessary. DISCUSSION: Surgical implantation of the new FlowSecure artificial urinary sphincter is an easy procedure in males with stress urinary incontinence. Knigth et al. reported 30 to 40 minutes operating time, 4 days mean hospital stay and unnecessary pressurisation procedure in 3 out of their 9 patients. It seems that their results are reproducible.

["Flowsecure" artificial urinary sphincter: a new adjustable artificial urinary sphincter concept with conditional occlusion for stress urinary incontinence]. / Esfínter Urinario Artificial "FlowSecure": un nuevo concepto de esfínter artificial regulable y con oclusión condicional para la incontinencia urinaria de esfuerzo.

INTRODUCTION: To spread de concept of a new artificial urinary sphincter with conditional occlusion for stress incontinence. The new prototype was conceived and designed in The Institute of Urology and Nephrology of London by Professor Craggs M. and Professor Mundy A.R. METHODS: The FlowSecure sphincter consists of an adjustable pressure-regulating balloon, a stress relief reservoir, a control pump and valve assembly unit with self-sealing port and a urethral cuff. The pressure regulating balloon determinates de operating pressure of the device; the pressure is adjustable in the range 0-80 cm H2O and can be altered by injection or removal of normal saline through the self sealing port. The stress relief balloon transmits transient intrabdominal pressure to the cuff during periods of stress. An adjustable circular urethral cuff minimises creasing and possible stress fractures. RESULTS: The device is implanted as a one-piece assembly which is pre-filled with sterile saline. The surgical technique is simple and associated with little handling, reducing risk of infection and potential assembly errors. The adjustable pressure regulating balloon in association with the stress relief reservoir enables the cuff occluding pressure to be set at a low range, therefore reducing the risk for atrophy and erosion. DISCUSSION: The new FlowSecure urinary artificial sphincter with conditional occlusion is designed to provide good continence rates adjusting regulating pressures when needed and conceived to reduce the risk of potential complications associated with excessive occluding pressures and mechanical failures.

Implantación del Esfínter Urinario Artificial 'FlowSecure(TM') en uretra bulbar: Descripción de la técnica quirúrgica paso a paso / 'Flowsecure(TM)' artificial urinary sphincter: a new adjustable artificial urinary sphincter concept with conditional occlusion for stress urinary incontinence

Introducción: En Octubre de 2006 se implantó por primera vez en nuestra Institución el nuevo esfínter urinario artificial FlowSecure TM. El prototipo fue concebido y diseñado por los Profesores Craggs MD y Mundy AR y los resultados clínicos preliminares de 9 pacientes fueron publicados a mediados del 2006. Nuestro objetivo es el de difundir la descripción detallada de la técnica quirúrgica para la implantación de esta nueva prótesis. Materiales y métodos: Se requiere una incisión perineal para la exposición de la uretra bulbar y una abdominal para la creación de un espacio paravesical y de un bolsillo escrotal. Se coloca un trocar con un estilete desde la incisión abdominal a la perineal para pasar el manguito desinflado, que se ajusta a la uretra y se asegura con tres puntos de Prolene. Tras volver a llenar el manguito se extrae líquido hasta que se forma una muesca en el reservorio de asistencia al estrés, indicando que el sistema está a presión atmosférica 0. Se coloca entonces la bomba en el escroto y los reservorios en el espacio paravesical. Resultados: El esfínter fue colocado en un paciente con incontinencia de esfuerzo tras una RTU de próstata. La técnica es simple, el paciente se fue de alta al cuarto día y no fue necesario presurizar el sistema porque el paciente recuperó la continencia desde la retirada de la sonda. Discusión: La implantación en uretra bulbar es muy sencilla. Los resultados en este paciente concuerdan con los de Knigth et al., que describen tiempo quirúrgico de 30 a 40 minutos, media de estancia hospitalaria de 4 días y presurización innecesaria en tres de sus nueve pacientes. Parece que la técnica y los resultados son reproducibles

Introduction: We have implanted the FlowSecure artificial sphincter for the first time in October 2006. The prototype was originally conceived and designed by Professor Craggs M. D. and Professor Mundy A.R. Preliminary clinical results were reported in nine patients early this year. Our objective is to spread technique for surgical implantation. Methods: Combined perineal and abdominal incisions are required for exposure of bulbar urethra, creation of a cavity in the para-vesical space and dissection of a pocket under de scrotal wall. A trocar with a stylet is routed from the abdominal incision to the perineal incision to pass the deflated cuff to the perineal site. The cuff is placed around the urethra and secured with Prolene sutures. After refilling the cuff, fluid is removed from the system until the stress relief balloon becomes just indented (atmospheric pressure 0). The pump is placed in the scrotum and the balloons in the paravesical space. Results: We have implanted our first FlowSecure artificial sphincter in a patient with severe stress incontinence following a T.U.R.P. The surgical technique is simple and associated with little handling. He was discharged from hospital 4 days after the procedure and it was decided that pressurisation was unnecessary. Discussion: Surgical implantation of the new FlowSecure artificial urinary sphincter is an easy procedure in males with stress urinary incontinence. Knigth et al. reported 30 to 40 minutes operating time, 4 days mean hospital stay and unnecessary pressurisation procedure in 3 out of their 9 patients. It seems that their results are reproducible

[The role of low urethral mucosal and submucosal blood perfusion in patients with artificial urinary sphincters]. / Importancia de la integridad de la mucosa y submucosa uretral en la continencia de los pacientes con esfínteres urinarios artificiales.

INTRODUCTION: A common complication following insertion of a bulbar AUS is recurrent incontinence, and once other causes have been ruled out, a diagnosis of urethral atrophy is then made. Urethral atrophy probably occurs to a certain degree in all patients with an AUS but the reappearance of incontinence is often attributed to inadequate pressure transfer from the cuff to the atrophic urethra. The normal urethral closure mechanism depends also on passive forces which rely on the integrity of the urethral mucosa and submucosa. MATERIAL AND METHODS: Two groups of patients with a first AUS implant which had been in place for more than 1 year were studied (n = 11). Group I consisted of continent patients (n(I) = 6) whereas Group II had significant incontinence due to urethral atrophy (n(II) = 5). Intraurethral pressures (IP) and blood flux (BF) were measured simultaneously with a micro-tip transducer and a laser Doppler flowmeter in each patient. Positional measurements were recorded proximal, within, and distal to the cuff first with the AUS deactivated and then activated. RESULTS: Group I patients exhibited similar IP and BF at all positions along the urethra. In Group II the IP was similar along the urethra but the BF within the cuff was qualitatively different (non pulsatile) and decreased significantly when compared to either side of the cuff during. DISCUSSION: Continence in patients with artificial urinary sphincters depends not only on the cuff occlusive force but is also dependent on the viability of the mucosal and submucosal tissues. For a given pressure range mucosal and submucosal blood perfusion is determinant. patients with normal blood perfusion would remain continent whereas patients with impaired perfusion would become incontinent.

Esfínter Urinario Artificial 'FlowSecure(TM)': un nuevo concepto de esfínter artificial regulable y con oclusión condicional para la incontinencia urinaria de esfuerzo / 'Flowsecure(TM)' artificial urinary sphincter: a new adjustable urinary sphincter concept with conditional occlusion for stress urinary incontinence

Introducción: Difundir el concepto de un nuevo esfínter urinario artificial con oclusión condicional para el tratamiento de la incontinencia urinaria de esfuerzo. El prototipo fue concebido y diseñado por los profesores Craggs M. y Mundy A.R. en el Instituto de Urología y Nefrología de Londres. Materiales y Métodos: El esfínter FlowSecure es un prototipo de una sola pieza de silicona llena de suero salino que consta de: 1) Un reservorio regulador de presión, 2) un reservorio de asistencia al estrés, 3) una bomba de control con un puerto autosellable y 4) un manguito. El reservorio regulador determina la presión de la prótesis y se puede ajustar desde 0 a 80 cm H2O mediante la inyección o extracción de líquido a través del puerto autosellable (oclusión basal). El reservorio de asistencia al estrés transmite de forma reversible los aumentos de la presión intra-abdominal durante los periodos de esfuerzo (oclusión condicional). Resultados: La técnica quirúrgica de implantación es simple, reduciendo la posibilidad de infección y errores de ensamblaje. La asociación en serie de un reservorio regulador de presión con un reservorio de asistencia al estrés permite establecer presiones de oclusión basal bajas y el aumento condicional de la misma durante los periodos de estrés, reduciendo el riesgo de atrofia y erosión. Tras la implantación, la presión es ajustable dependiendo de las necesidades clínicas del paciente. Discusión: El esfínter FlowSecure está diseñado para corregir la incontinencia ajustando la presión de oclusión según las necesidades individuales de cada paciente, así como para reducir las complicaciones asociadas al exceso de presión de oclusión y los fallos mecánicos

Introduction: To spread de concept of a new artificial urinary sphincter with conditional occlusion for stress incontinence. The new prototype was conceived and designed in The Institute of Urology and Nephrology of London by Professor Craggs M. and Professor Mundy A.R. Methods: The FlowSecure sphincter consists of an adjustable pressure-regulating balloon, a stress relief reservoir, a control pump and valve assembly unit with self-sealing port and a urethral cuff. The pressure regulating balloon determinates de operating pressure of the device; the pressure is adjustable in the range 0-80 cm H2O and can be altered by injection or removal of normal saline through the self sealing port. The stress relief balloon transmits transient intrabdominal pressure to the cuff during periods of stress. An adjustable circular urethral cuff minimises creasing and possible stress fractures. Results: The device is implanted as a one-piece assembly which is pre-filled with sterile saline. The surgical technique is simple and associated with little handling, reducing risk of infection and potential assembly errors. The adjustable pressure regulating balloon in association with the stress relief reservoir enables the cuff occluding pressure to be set at a low range, therefore reducing the risk for atrophy and erosion. Discussion: The new FlowSecure urinary artificial sphincter with conditional occlusion is designed to provide good continence rates adjusting regulating pressures when needed and conceived to reduce the risk of potential complications associated with excessive occluding pressures and mechanical failures

Importancia de la integridad de la mucosa y submucosa uretral en la continencia de los pacientes con esfínteres urinarios artificiales / The role of low urethral mucosal and submucosal blood perfusion in patients with artificial urinary sphincters

Introducción: La reaparición de incontinencia por atrofia uretral en pacientes con esfínteres urinarios artificiales (EUA) tradicionalmente ha sido atribuida al déficit de transmisión de la presión oclusiva. Existe, sin embargo, una fuerza pasiva que reside en la mucosa y submucosa uretral y contribuye al sellado de la luz uretral. Nuestro objetivo fue determinar el papel de la mucosa y submucosa uretral en la continencia de los pacientes con EUA en la uretra bulbar. Materiales y Métodos: Se estudiaron dos grupos de pacientes con un EUA in situ durante más de 1 año (n total = 11). El grupo I estaba constituido por pacientes continentes (nI = 6) y el grupo II por pacientes incontinentes debido a atrofia uretral (nII = 5). Se valoró la presión intrauretral (PI) y la perfusión sanguínea (PS) de la mucosa y submucosa de forma simultánea con la técnica de microtransductor multicanal y láser-doppler respectivamente. El estudio se realizó comparando la PI y la PS de la uretra proximal y distal al manguito con la PI y la PS del segmento uretral por debajo del manguito en cada uno de los pacientes. Resultados: La PS del grupo I (continente) no varió de forma significativa a lo largo de la uretra. La PS del grupo II (incontinente por atrofia uretral) fue significativamente menor por debajo del manguito que en la uretra proximal y distal. La IP del tramo uretral por debajo del manguito de ambos grupos no presentó diferencias significativas. Discusión: La continencia de los pacientes con EUA depende de dos factores: 1) la presión que el manguito ejerce sobre la uretra bulbar y 2) la preservación de la perfusión sanguínea de la mucosa y submucosa uretral. Para un determinado rango de presiones en el manguito, el factor más importante es la perfusión sanguínea uretral. Los pacientes con buena perfusión permanecerán continentes y aquellos en los que la isquemia impide el efecto de sellado de la mucosa y submucosa desarrollarán incontinencia

Introduction: A common complication following insertion of a bulbar AUS is recurrent incontinence, and once other causes have been ruled out, a diagnosis of urethral atrophy is then made. Urethral atrophy probably occurs to a certain degree in all patients with an AUS but the reappearance of incontinence is often attributed to inadequate pressure transfer from the cuff to the atrophic urethra. The normal urethral closure mechanism depends also on passive forces which rely on the integrity of the urethral mucosa and submucosa. Material and Methods: Two groups of patients with a first AUS implant which had been in place for more than 1 year were studied (n=11). Group I consisted of continent patients (nI=6) whereas Group II had significant incontinence due to urethral atrophy (nII=5). Intraurethral pressures (IP) and blood flux (BF) were measured simultaneously with a micro-tip transducer and a laser Doppler flowmeter in each patient. Positional measurements were recorded proximal, within, and distal to the cuff first with the AUS deactivated and then activated. Results: Group I patients exhibited similar IP and BF at all positions along the urethra. In Group II the IP was similar along the urethra but the BF within the cuff was qualitatively different (non pulsatile) and decreased significantly when compared to either side of the cuff during. Discussion: Continence in patients with artificial urinary sphincters depends not only on the cuff occlusive force but is also dependent on the viability of the mucosal and submucosal tissues. For a given pressure range mucosal and submucosal blood perfusion is determinant: patients with normal blood perfusion would remain continent whereas patients with impaired perfusion would become incontinent

Diagnostic accuracy of flow rate testing in urology.

OBJECTIVE: To highlight the importance of methodological standards in diagnostic testing in urology, by reviewing the extent of compliance with these standards in reports of published evaluations. METHODS: Sixteen papers evaluating the diagnostic accuracy of urinary flow-rate testing were independently assessed by two reviewers for compliance with the following methodological standards: specification of study population, analysis of pertinent subgroups, avoidance of evaluation (verification) bias, avoidance of review bias, reporting of precision of estimates of test accuracy, indeterminate test results, and test reproducibility. Compliance with each standard was expressed as a percentage with a 95% confidence interval. RESULTS: Compliance ranged from just 12.5 (1.5-38)% for reporting of test reproducibility to 87.5 (62-98)% for specification of the study population. Only nine of the 16 evaluations complied with four or more of the methodological standards; one paper did not comply with any. CONCLUSIONS: This evaluation of urological flow-rate testing show poor compliance with accepted methodological standards. The study design, reporting and evaluation of new diagnostic tests can be improved by adhering to these standards. Policy-makers, purchasers and providers would be less likely to adopt new diagnostic tests inappropriately if they were to appraise published evaluations against the standards. A reduction in the inappropriate use of tests would in turn lead to more cost-effective use of healthcare resources.